PFF In The Media

  • Aug 06, 2020

    Inverness Resident Calling Attention To Life-Threatening Disease

    Inverness resident Fredrick Schick, an experienced swimmer, is serving as an ambassador for a national organization in an effort to call attention to a life-threatening disease.

    Link to Article
    Source: Daily Herald
  • Sep 01, 2020

    Guidance for Using High-Resolution CT for Interstitial Lung Disease

    The Pulmonary Fibrosis Foundation (PFF) has issued a position statement that serves as a guide for conducting high-resolution computed tomography (HRCT) of the thorax for interstitial lung disease (ILD).

    Link to Article
    Source: RT Magazine
  • Sep 01, 2020

    Driving research and awareness of pulmonary fibrosis: Pulmonary Fibrosis Foundation is leading the path to a cure

    Each September, more than 200,000 Americans living with pulmonary fibrosis (PF) unite in elevating the disease profile during Pulmonary Fibrosis Awareness Month.

    Link to Article
    Source: American Journal of Physiology - Lung Cellular and Molecular Physiology
  • Sep 10, 2020

    Pulmonary Fibrosis Awareness Month Shines a Spotlight on Largely Unsuspected Lung Disease

    Dry cough. Fatigue. Shortness of breath. Amidst a pandemic, these symptoms appear as tell-tale signs of COVID-19.

    Link to Article
    Source: Thrive Global
  • Sep 14, 2020

    Pulmonary Fibrosis: The Unsuspected Disease Affecting Over 200K Americans

    While many people have heard of chronic lung diseases like COPD, asthma and cystic fibrosis, few are familiar with the interstitial lung diseases, also called pulmonary fibrosis (PF).

    Link to Article
    Source: Medium.com
  • Sep 23, 2020

    Dr. Sonye Danoff, Facts About Pulmonary Fibrosis

    September is National Pulmonary Fibrosis Awareness Month and more than 200,000 Americans are living with pulmonary fibrosis, a lung disease with no known cure.

    Link to Article
    Source: Business Radio X
  • Oct 26, 2020

    Know these Pulmonary Fibrosis Risk Factors

    October is Healthy Lung Month, an apt time to educate the public about the importance of protecting our lungs against mold, airborne pollutants and smoking – which put hundreds of thousands of Americans at higher risk for pulmonary fibrosis (PF).

    Link to Article
    Source: Today’s Caregiver
  • Oct 25, 2020

    Clinical Challenges: Diagnosing Idiopathic Lung Fibrosis

    Approval of two antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) -- pirfenidone (Esbriet) and nintedanib (Ofev) -- represented a paradigm shift in the management of the progressive fibrotic disease and potentially other interstitial lung diseases, ushering in the era of therapies that can slow lung scarring progression.

    Link to Article
    Source: MedPage Today
  • Nov 10, 2020

    What You Should Know About Pulmonary Fibrosis

    Have you heard of pulmonary fibrosis? If you answered no, you are not alone.

    Link to Article
    Source: The Mighty.com
  • Jan 04, 2021

    Resolve to talk to your doctor in the New Year

    The New Year is the perfect time to advocate for your health and commit to listening to your body for any new symptoms or warning signs.

    Link to Article
    Source: Newswire
  • Feb 01, 2021

    PFF Patients Advocate and Inspire for National Patient Recognition Week

    Sharing patient stories can help spread awareness for little-known diseases like pulmonary fibrosis, empowering patients to build support systems, pinpoint symptoms and take action early.

    Link to Article
    Source: Medium
  • Feb 01, 2021

    The pulmonary fibrosis treatment landscape: An interview with an expert

    In 2014, FDA approved two medications for idiopathic pulmonary fibrosis (IPF) — nintedanib from Boehringer Ingelheim and pirfenidone from Roche (OTCMKTS:RHHBY).

    Link to Article
    Source: Drug Discovery & Development
  • Feb 15, 2021

    My Breath, Made Possible by Another: Lung Transplants and Pulmonary Fibrosis

    According to the Organ Procurement and Transplantation Network, a patient in need of a life-saving organ transplant is added to the national waiting list every 9 minutes*.

    Link to Article
    Source: Medium.com
  • Apr 01, 2021

    Early Diagnosis for Pulmonary Fibrosis is Key

    Pulmonary fibrosis (PF) continues to be relatively unknown among the public, making awareness and education critically important.

    Link to Article
    Source: VFW Magazine
  • Mar 23, 2021

    Local pulmonary fibrosis ambassador goes to Washington

    On March 10, Debbie Herndon, Boise resident and ambassador for the Pulmonary Fibrosis Foundation, traveled (virtually) to Washington, D.C., with a group of fellow advocates from around the country to drive awareness and research funding for the disease.

    Link to Article
    Source: Idaho Press
  • Apr 03, 2021

    The Deadly Lung Disease You've Probably Never Heard Of

    Pulmonary fibrosis (PF) is an uncommon and frequently fatal lung disease, and the road to diagnosis can be long and difficult.

    Link to Article
    Source: Scientific America
  • Sep 05, 2019

    September Marks Pulmonary Fibrosis Awareness Month

    September has been designated Pulmonary Fibrosis Awareness Month — a time during which researchers and clinicians aim to improve the public’s knowledge about the disease.

    Link to Article
    Source: Healio
  • Sep 03, 2019

    Charlotte pastor turns near-death experience into chance to help community

    A Charlotte pastor is turning his near-death experience into an effort to help his community.

    Link to Article
    Source: WSOC-TV Charlotte